Vonoprazan

🧮 Dose calculator

Erosive esophagitis (GERD) · Regimen source: FDA Voquezna · 2.1

• • Maintenance: 10 mg once daily up to 6 months. GFR <30: 10 mg. FDA Voquezna · 2.1FDA Voquezna · 2.2, Table 1

Enter age (weight is optional for this regimen).

👥 Special populations

• 🤰 PregnancyUse with caution

  Label states no clear risk or has limited data; use only if needed, under medical advice. FDA Voquezna · 8.1

  “Risk Summary There are no adequate and well-controlled studies of vonoprazan in pregnant women.”

• 🤱 BreastfeedingUse with caution

  Label: use with caution while breastfeeding; see the label text. FDA Voquezna · 8.2

  “Risk Summary Data from a clinical lactation study indicate that vonoprazan is present in human breast milk in amounts less than 0.03% of the administered maternal dose.”

• 👶 ChildrenUse with caution

  The label has conditions, age limits or notes for children; the label sentence is quoted below. FDA Voquezna · 8.4

  “The safety and effectiveness of VOQUEZNA have not been established in pediatric patients.”

• 👴 Older adultsUse with caution

  Label: use with caution in older adults, usually starting at the low end of the dose range. FDA Voquezna · 8.5

  “There were 200 patients aged 65 years and older in the clinical trial for healing and maintenance of healed erosive esophagitis [see Clinical Studies (14.1) ] .”

• ⚥ Females & males of reproductive potentialNo data

  The source for this drug has no section for this group.